Transcription factor IIIB: An important determinant of biosynthetic capacity that is targeted by tumour suppressors and transforming proteins (review)

International Journal of Oncology

Volumn 12, Issue 4, 1998, Pages 741-748

  White, Robert J ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Cell cycle; Pol III; Retinoblastoma protein; Transcription; Transcription factor IIIB; Transformation

Indexed keywords

DNA DIRECTED RNA POLYMERASE III; PHOSPHOPROTEIN; PHOSPHOPROTEIN DR 1; PROTEIN P53; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR IIIB; UNCLASSIFIED DRUG; ONCOPROTEIN; RNA;

ADENOVIRUS; CELL CYCLE; CELL DIFFERENTIATION; CELL GROWTH; CELL TRANSFORMATION; HEPATITIS B VIRUS; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; NONHUMAN; PRIORITY JOURNAL; REVIEW; RNA SYNTHESIS; SIMIAN VIRUS 40; TRANSCRIPTION REGULATION; ANIMAL; BIOSYNTHESIS; PHYSIOLOGY; TUMOR SUPPRESSOR GENE;

ANIMALS; CELL CYCLE; CELL TRANSFORMATION, NEOPLASTIC; GENES, P53; HUMANS; ONCOGENE PROTEINS, VIRAL; RETINOBLASTOMA PROTEIN; RNA; TRANSCRIPTION FACTOR TFIIIB; TRANSCRIPTION FACTORS;

EID: 0031594762     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (107)

1. Willis IM: RNA polymerase III. Genes, factors and transcriptional specificity. Eur J Biochem 212: 1-11, 1993 .
2. White RJ: RNA polymerase III transcription. R.G. Landes Company, Austin, 1994.
3. Kassavetis GA, Braun BR, Nguyen LH and Geiduschek EP: S. cerevisiae TFIIIB is the transcription initiation factor proper of RNA polymerase III, while TFIIIA and TFIIIC are assembly factors. Cell 60: 235-245, 1990.
4. Bartholomew B, Kassavctis GA and Geiduschek EP: Two components of Saccharomyces cerevisiae transcription factor IIIB (TFIIIB) arc stereospecifically located upstream of a tRNA gene and interact with the second-largest subunit of TFIIIC. Mol Cell Biol 11:5181-5189, 1991.
5. Hernandez N: TBP, a universal eukaryotic transcription factor? Genes Dev 7: 1291-1308, 1993.
6. Rigby PWJ: Three in one and one in three: it all depends on TBP. Cell 72: 7-10, 1993.
7. Kassavetis GA, Joazeiro CAP, Pisano M, Geiduschek EP, Colbert T, Hahn S and Blanco JA: The role of the TATA-binding protein in the assembly and function of the multi-subunit yeast RNA polymerase III transcription factor, TFIIIB. Cell 71: 1055-1064,1992.
8. Kassavetis GA, Nguyen ST, Kobayashi R, Kumar A, Geiduschek EP and Pisano M: Cloning, expression, and function of TFC5, the gene encoding the B″ component of the Saccharomyces cerevisiae RNA polymerase III transcription factor TFIIIB. Proc Natl Acad Sci USA 92: 9786-9790, 1995.
9. Roberts S, Miller SJ, Lane WS, Lee S and Hahn S: Cloning and functional characterization of the gene encoding the TFIIIB90 subunit of RNA polymerase III transcription factor TFIIIB. J Biol Chem 271: 14903-14909, 1996.
10. Ruth J, Conesa C, Dieci G, Lefebvre O, Dusterhoft A, Ottonello S and Sentenac A: A suppressor of mutations in the class III transcription system encodes a component of yeast TFIIIB. EMBO J 15: 1941-1949, 1996.
11. Buratowski S and Zhou H: A suppressor of TBP mutations encodes an RNA polymerase III transcription factor with homology to TFHB. Cell 71: 221-230, 1992.
12. Colbert T and Hahn S: A yeast TFIIB-related factor involved in RNA polymerase III transcription. Genes Dev 6: 1940-1949, 1992.
13. Lopez-de-Leon A, Librizzi M, Tuglia K and Willis I: PCF4 encodes an RNA polymerase III transcription factor with homology to TFIIB. Cell 71: 211-220, 1992.
14. Aasland R, Stewart AF and Gibson T: The SANT domain: a putative DNA-binding domain in the SWI-SNF and ADA complexes, the transcriptional corepressor N-CoR and TFIIIB. Trends Biochem Sci 21: 87-88, 1996.
15. Wang Z and Roeder RG: Structure and function of a human transcription factor TFIIIB subunit that is evolutionarily conserved and contains both TFIIB- and high-mobility-group protein 2-related domains. Proc Natl Acad Sci USA 92: 7026-7030, 1995.
16. Mitai R, Kobayashi R and Hernandez N: RNA polymerase III transcription from the human U6 and adenovirus type 2 VAI promoters has different requirements for human BRF, a subunit of human TFIIIB. Mol Cell Biol 16:7031-7042, 1996.
17. Vilalta A, Trivedi A, Wang Z, Roeder RG and Johnson DL: An RNA polymerase III-defective mutation in TATA-binding protein disrupts its interaction with a transcription factor IIIB subunit in Drosophila cells. J Biol Chem 272: 18087-18092, 1997.
18. Larminie CGC and White RJ: Identification of a putative BRF homologue in the genome of Caenorhabditis elegans. DNA Sequence (In press).
19. Lobo SM, Lister J, Sullivan ML and Hernandez N: The cloned RNA polymerase II transcription factor IID selects RNA polymerase III to transcribe the human U6 gene in vitro. Genes Dev 5: 1477-1489, 1991.
20. Margottin F, Dujardin G, Gerard M, Egly JM, Huet J and Sentenac A: Participation of the TATA factor in transcription of the yeast U6 gene by RNA polymerase C. Science 251: 424-426, 1991.
21. Simmen KA, Bernues J, Parry HD, Stunnenberg HG, Berkenstam A, Cavallini B, Egly JM and Mattaj IW: TFIID is required for in vitro transcription of the human U6 gene by RNA polymerase III. EMBO J 10: 1853-1862, 1991.
22. Joazeiro CAP, Kassavetis GA and Geiduschek EP: Identical components of yeast transcription factor IIIB are required and sufficient for transcription of TATA box-containing and TATA-less genes. Mol Cell Biol 14: 2798-2808, 1994.
23. Geiduschek EP and Kassavetis GA: Comparing transcriptional initiation by RNA polymerases I and III. Curr Opin Cell Biol 7: 344-351, 1995.
24. Vasseur M, Condamine H and Duprey P: RNAs containing B2 repeated sequences are transcribed in the early stages of mouse embryogenesis. EMBO J 4: 1749-1753, 1985.
25. Murphy D, Brickcll PM, Latchman DS, Willison K and Rigby PWJ: Transcripts regulated during normal embryonic development and oncogenic transformation share a repetitive element. Cell 35: 865-871, 1983.
26. White RJ, Stott D and Rigby PWJ: Regulation of RNA polymerase III transcription in response to F9 embryonal carcinoma stem cell differentiation. Cell 59: 1081-1092, 1989.
27. Gottesfeld JM and Forbes DJ: Mitotic repression of the transcriptional machinery. Trends Biochem Sci 22: 197-202, 1997.
28. Gottesfeld JM, Wolf VJ, Dang T, Forbes DJ and Hartl P: Mitotic repression of RNA polymerase III transcription in vitro mediated by phosphorylation of a TFIIIB component. Science 263: 81-84, 1994.
29. White RJ, Gottlieb TM, Downes CS and Jackson SP: Mitotic regulation of a TATA-binding-protein-containing complex. Mol Cell Biol 15: 1983-1992, 1995.
30. Leresche A, Wolf VJ and Gottesfeld JM: Repression of RNA polymerase II and III transcription during M phase of the cell cycle. Exp Cell Res 229: 282-288, 1996.
31. Hartl P, Gottesfeld J and Forbes DJ: Mitotic repression of transcription in vitro. J Cell Biol 120: 613-624, 1993.
32. White RJ, Gottlieb TM, Downes CS and Jackson SP: Cell cycle regulation of RNA polymerase III transcription. Mol Cell Biol 15: 6653-6662, 1995.
33. Sherr CJ: G1 phase progression: cycling on cue. Cell 79: 551-555, 1994.
34. Strauss M, Lukas J and Bartek J: Unrestricted cell cycling and cancer. Nat Med 1: 1245-1246, 1995.
35. Weinberg RA: The retinoblastoma protein and cell cycle control. Cell 81: 323-330, 1995.
36. Whyte P: The retinoblastoma protein and its relatives. Semin Cancer Biol 6: 83-90, 1995.
37. White RJ, Trouche D, Martin K, Jackson SP and Kouzarides T: Repression of RNA polymerase III transcription by the retinoblastoma protein. Nature 382: 88-90, 1996.
38. Chu W-M, Wang Z, Roeder RG and Schmid CW: RNA polymerase III transcription repressed by Rb through its interactions with TFIIIB and TFIIIC2. J Biol Chem 272: 14755-14761, 1997.
39. Larminie CGC, Cairns CA, Mital R, Martin K, Kouzarides T, Jackson SP and White RJ: Mechanistic analysis of RNA polymerase III regulation by the retinoblastoma protein. EMBO J 16: 2061-2071, 1997.
40. Chesnokov I, Chu W-M, Botchan MR and Schmid CW: p53 inhibits RNA polymerase Ill-directed transcription in a promoter-dependent manner. Mol Cell Biol 16: 7084-7088, 1996.
41. White RJ, Khoo BC-E, Inostroza JA, Rcinbcrg D and Jackson SP: The TBP-binding repressor Dr1 differentially regulates RNA polymerases I, II and III. Science 266:448-450, 1994.
42. Inostroza JA, Mermelstein FH, Ha I, Lane WS and Reinberg D: DrI, a TATA-binding protein-associated phosphoprotein and inhibitor of class II gene transcription. Cell 70: 477-489, 1992.
43. Kim S, Na JG, Hampscy M and Reinberg D: The Dr1/DRAP1 heterodimer is a global repressor of transcription in vivo. Proc Natl Acad Sci USA 94: 820-825, 1997.
44. Kuromori T and Yamamoto M: Cloning of cDNAs from Arabidopsis thaliana that encode putative protein phosphatase 2C and a human Dr1-like protein by transformation of a fission yeast mutant. Nucleic Acids Res 22: 5296-5301, 1994.
45. Johnson LF, Abelson HT, Green H and Penman S: Changes in RNA in relation to growth of the fibroblast. I. Amounts of mRNA, rRNA, and tRNA in resting and growing cells. Cell 1: 95-100, 1974.
46. Mauck JC and Green H: Regulation of pre-transfer RNA synthesis during transition from resting to growing state. Cell 3: 171-177, 1974.
47. Carey MF and Singh K: Enhanced B2 transcription in simian virus 40-transformed cells is mediated through the formation of RNA polymerase III transcription complexes on previously inactive genes. Proc Natl Acad Sci USA 85: 7059-7063, 1988.
48. Hoeffler WK, Kovelman R and Roeder RG: Activation of transcription factor IIIC by the adenovirus E1A protein. Cell 53: 907-920, 1988.
49. Tower J and Sollner-Webb B: Polymerase III transcription factor B activity is reduced in extracts of growth-restricted cells. Mol Cell Biol 8: 1001-1005, 1988.
50. Sethy I, Moir RD, Librizzi M and Willis IM: In vitro evidence for growth regulation of tRNA gene transcription in yeast. J Biol Chem 270: 28463-28470, 1995.
51. Clarke EM, Peterson CL, Brainard AV and Riggs DL: Regulation of the RNA polymerase I and III transcription systems in response to growth conditions. J Biol Chem 271: 22189-22195, 1996.
52. Kovelman R and Roeder RG: Purification and characterization of two forms of human transcription factor IIIC. J Biol Chem 267: 24446-24456, 1992.
53. Sinn E, Wang Z, Kovelman R and Roeder RG: Cloning and characterization of a TFIIIC2 subunit (TFIIICß) whose presence correlates with activation of RNA polymerase III-mediated transcription by adenovirus E1A expression and serum factors. Genes Dev 9: 675-685, 1995.
54. Weinmann R, Raskas HJ and Roeder RG: Role of DNA-dependent RNA polymerases II and III in transcription of the adenovirus genome late in productive infection. Proc Natl Acad Sci USA 71: 3426-3430, 1974.
55. Soderlund H, Pettersson U, Vennstom B, Philipson L and Mathews MB: A new species of virus-coded low molecular weight RNA from cells infected with adenovirus type 2. Cell 7: 585-593, 1976.
56. Thimmappaya B, Weinberger C, Schneider RJ and Shenk T: Adenovirus VAI RNA is required for efficient translation of viral mRNA at late times after infection. Cell 31: 543-551, 1982.
57. Hoeffler WK and Roeder RG: Enhancement of RNA polymerase III transcription by the E1A gene product of adenovirus. Cell 41: 955-963, 1985.
58. Yoshinaga S, Dean N, Han M and Berk AJ: Adenovirus stimulation of transcription by RNA polymerase III: evidence for an E1A-dependent increase in transcription factor IIIC concentration. EMBO J 5: 343-354, 1986.
59. Kraus VB, Inostroza JA, Yeung K, Reinberg D and Nevins JR: Interaction of the Dr1 inhibitory factor with the TATA binding protein is disrupted by adenovirus E1A. Proc Natl Acad Sci USA 91: 6279-6282, 1994.
60. Scott MRD, Westphal K-H and Rigby PWJ: Activation of mouse genes in transformed cells. Cell 34: 557-567, 1983.
61. Singh K, Carey M, Saragosti S and Botchan M: Expression of enhanced levels of small RNA polymerase III transcripts encoded by the B2 repeats in simian virus 40-transformed mouse cells. Nature 314: 553-556, 1985.
62. Carey MF, Singh K, Botchan M and Cozzarelli NR: Induction of specific transcription by RNA polymerase III in transformed cells. Mol Cell Biol 6: 3068-3076, 1986.
63. White RJ, Stott D and Rigby PWJ: Regulation of RNA polymerase III transcription in response to simian virus 40 transformation. EMBO J 9: 3713-3721, 1990.
64. De Caprio JA, Ludlow JW, Figge J, Shew J-Y, Huang C-M, Lee W-H, Marsilio E, Paucha E and Livingston DM: SV40 large tumour antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell 54: 275-283, 1988.
65. Moran E: A region of SV40 large T antigen can substitute for a transforming domain of the adenovirus E1A products. Nature 334: 168-170, 1988.
66. Rb and a second cellular protein, p120. Cell 58: 257-267, 1989.
67. Ludlow JW, De Caprio JA, Huang C-M, Lee W-H, Paucha E and Livingston DM: SV40 large T antigen binds preferentially to an underphosphorylated member of the retinoblastoma susceptibility gene product family. Cell 56: 57-65, 1989.
68. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD and Gallo RC: Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 77: 7415-7419, 1980.
69. Jacobson S, Raine CS, Mingioli ES and McFarlin DE: Isolation of an HTLV-I-Iike retrovirus from patients with tropical spastic paraparesis. Nature 331: 540-543, 1988.
70. Piras G, Dittmer J, Radonovich MF and Brady JN: Human T-cell leukaemia virus type I Tax protein transactivates RNA polymerase III promoter in vitro and in vivo. J Biol Chem 271: 20501-20506, 1996.
71. Gottesfeld JM, Johnson DL and Nyborg JK: Transcriptional activation of RNA polymerase III-dependent genes by the human T-cell leukaemia virus type 1 Tax protein. Mol Cell Biol 16: 1777-1785, 1996.
72. Kim C-M, Koike K, Saito I, Miyamura T and Jay G: HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature 351: 317-320, 1991.
73. Aufiero B and Schneider RJ: The hepatitis B virus X-gcne product transactivates both RNA polymerase II and III promoters. EMBO J 9: 497-504, 1990.
74. Kwee L, Lucito R, Aufiero B and Schneider RJ: Alternate translation initiation on hepatitis B virus X mRNA produces multiple polypeptides that differentially transactivate class II and III promoters. J Virol 66: 4382-4389, 1992.
75. Wang H-D, Yuh C-H, Dang CV and Johnson DL: The hepatitis B virus X protein increases the cellular level of TATA-binding protein, which mediates transactivation of RNA polymerase III genes. Mol Cell Biol 15: 6720-6728, 1995.
76. Wang H-D, Trivedi A and Johnson DL: Hepatitis B virus X protein induces RNA polymerase III-dependent gene transcription and increases cellular TATA-binding protein by activating the Ras signalling pathway. Mol Cell Biol 17: 6838-6846, 1997.
77. Trivedi A, Vilalta A, Gopalan S and Johnson DL: TATA-binding protein is limiting for both TATA-containing and TATA-lacking RNA polymerase III promoters in Drosophila cells. Mol Cell Biol 16:6909-6916, 1996.
78. Benn J and Schneider RJ: Hepatitis B virus HBx protein activates Ras-GTP complex formation and establishes a Ras, Raf, MAP kinase signaling cascade. Proc Natl Acad Sci USA 91: 10350-10354, 1990.
79. Kekule AS, Lauer U, Weiss L, Luber B and Hofschneider PH: Hepatitis B virus transactivator HBx uses a tumour promoter signalling pathway. Nature 361: 742-745, 1993.
80. + RNA. Nucleic Acids Res 10: 7477-7491, 1982.
81. Brickell PM, Latchman DS, Murphy D, Willison K and Rigby PWJ: Activation of a Qa/T1a class I major histocompatibility antigen gene is a general feature of oncogenesis in the mouse. Nature 306: 756-760, 1983.
82. Majello B, La Mantia G, Simeone A, Boncinelli E and Lania L: Activation of major histocompatibility complex class I mRNA containing an Alu-like repeat in polyoma virus-transformed rat cells. Nature 314: 457-459, 1985.
83. + RNA from mouse tissues. FEBS Lett 182: 73-76, 1985.
84. Lania L, Pannuti A, La Mantia G and Basilico C: The transcription of B2 repeated sequences is regulated during the transition from quiescent to proliferative state in cultured rodent cells. FEBS Lett 219: 400-404, 1987.
85. + RNAs are transcribed by RNA polymerase III in murine tumor cells. Nucleic Acids Res 18: 4499-4506, 1990.
86. Garber M, Panchanathan S, Fan RS and Johnson DL: The phorbol ester, 12-O-tetradecanoylphorbol-13-acetate, induces specific transcription by RNA polymerase III in Drosophila Schneider cells. J Biol Chem 266: 20598-20601, 1991.
87. Garber M, Vilalta A and Johnson DL: Induction of Drosophila RNA polymerase III gene expression by the phorbol ester 12-O-tetradecanoylphorbol-13-acetate (TPA) is mediated by transcription factor IIIB. Mol Cell Biol 14: 339-347, 1994.
88. Chen W, Heierhorst J, Brosius J and Tiedge H: Expression of neural BC1 RNA: induction in murine tumours. Eur J Cancer 33: 288-292, 1997.
89. Hu Q, Dyson N and Harlow E: The regions of the retinoblastoma protein needed for binding to adenovirus E1A or SV40 large T antigen are common sites for mutations. EMBO J 9: 1147-1155, 1990.
90. Horowitz JM, Park S-H, Bogenmann E, Cheng J-C, Yandell DW, Kaye FJ, Minna JD, Dryja TP and Weinberg RA: Frequent inactivation of the retinoblastoma anti-oncogene is restricted to a subset of human tumour cells. Proc Natl Acad Sci USA 87: 2775-2779, 1990.
91. Kaye FJ, Kratzke RA, Gerster JL and Horowitz JM: A single amino acid substitution results in a retinoblastoma protein defective in phosphorylation and oncoprotein binding. Proc Natl Acad Sci USA 87: 6922-6926, 1990.
92. Hollstein M, Rice K, Greenblatt MS, Soussi T, Fucks R, Sorlie T, Hovig E, Smith-Sorensen B, Montesano R and Harris CC: Database of p53 gene somatic mutations in human tumors and cell lines. Nucleic Acids Res 22: 3551-3555, 1994.
93. Lowry DR and Willumsen BM: Function and regulation of Ras. Annu Rev Biochem 62: 851-891, 1993.
94. Baxter GC and Stanners CP: The effect of protein degradation on cellular growth characteristics. J Cell Physiol 96: 139-146, 1978.
95. Brooks RF: Continuous protein synthesis is required to maintain the probability of entry into S phase. Cell 12: 311-317, 1977.
96. Ronning OW, Lindmo T, Pettersen EO and Seglen PO: The role of protein accumulation in the cell cycle control of human NHIK 3035 cells. J Cell Physiol 109:411-418, 1981.
97. Stanners CP, Adams ME, Harkins JL and Pollard JW: Transformed cells have lost control of ribosome number through their growth cycle. J Cell Physiol 100: 127-138, 1979.
98. Kief DR and Warner JR: Coordinate control of syntheses of ribosomal ribonucleic acid and ribosomal proteins during nutritional shift-up in Saccharomyces cerevisiae. Mol Cell Biol 1: 1007-1015, 1981.
99. Tatsuka M, Mitsui H, Wada M, Nagata A, Nojima H and Okayama H: Elongation factor-1α gene determines susceptibility to transformation. Nature 359: 333-335, 1992.
100. Redpath NT and Proud CG: Molecular mechanisms in the control of translation by hormones and growth factors. Biochim Biophys Acta 1220: 147-162, 1994.
101. Rosenwald IB: Deregulation of protein synthesis as a mechanism of neoplastic transformation. Bioessays 18: 243-250, 1996.
102. Rosenwald IB: Upregulated expression of the genes encoding translation initiation factors eIF-4E and eIF-2α in transformed cells. Cancer Lett 102: 113-123, 1996.
103. Killander D and Zetterberg A: A quantitative cytochemical investigation of the relationship between cell mass and initiation of DNA synthesis in mouse fibroblasts in vitro. Exp Cell Res 40: 12-20, 1965.
104. Terasima T and Yasukawa M: Synthesis of G1 protein preceding DNA synthesis in cultured mammalian cells. Exp Cell Res 44: 669-672, 1966.
105. Nasmyth K: Another role rolls in. Nature 382: 28-29, 1996.
106. White RJ: Regulation of RNA polymerases I and III by the retinoblastoma protein: a mechanism for growth control? Trends Biochem Sci 22: 77-80, 1997.
107. Larminie CGC, Alzuherri HM, Cairns CA, McLees A and White RJ: Transcription by RNA polymerases I and III: a potential link between cell growth, protein synthesis and the retinoblastoma protein. J Mol Med 76: 94-103, 1998.